Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.

Breccia M, Palandri F, Guglielmelli P, Palumbo GA, Malato A, Mendicino F, Ricco A, Sant'Antonio E, Tiribelli M, Iurlo A

DOI: 10.3390/curroncol29070395
Published: 2022 Jul 15
Container: Current oncology (Toronto, Ont.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/curroncol29070395,
  title = {Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.},
  author = {Breccia M and Palandri F and Guglielmelli P and Palumbo GA and Malato A and Mendicino F and Ricco A and Sant'Antonio E and Tiribelli M and Iurlo A},
  year = {2022},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol29070395},
  url = {https://doi.org/10.3390/curroncol29070395}
}

RIS

TY  - JOUR
TI  - Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.
AU  - Breccia M
AU  - Palandri F
AU  - Guglielmelli P
AU  - Palumbo GA
AU  - Malato A
AU  - Mendicino F
AU  - Ricco A
AU  - Sant'Antonio E
AU  - Tiribelli M
AU  - Iurlo A
PY  - 2022
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol29070395
UR  - https://doi.org/10.3390/curroncol29070395
ER  -

APA

M, B., F, P., P, G., GA, P., A, M., F, M., A, R., E, S., M, T., & A, I. (2022). Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol29070395

Source records

pubmed · retrieved 2026-09-26T20:51:02.422Z